Brief: Cyclopharm Secures Maximum U.S. Patent Extension For Technegas To 2031
11/06/2025 02:41
June 11 (Reuters) - Cyclopharm Ltd CYC.AX: SECURES MAXIMUM U.S. PATENT EXTENSION FOR TECHNEGAS TO 2031 Further company coverage: CYC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair